Global Point-of-Care or Rapid Diagnostics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 25-Oct-2021
No. of pages: 117

The Point-Of-Care Or Rapid Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Point-Of-Care Or Rapid Diagnostics size is estimated to be XX million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Point-Of-Care Or Rapid Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Point-Of-Care Or Rapid Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Intensive Care

- Covid-19 Testing

- Infectious Diseases Testing

- Cardiac Markers Testing

- Coagulation Testing

- Others

Market segment by Application can be divided into

- Hospital

- Clinic

- Independent Laboratories

- Others

The key market players for global Point-Of-Care Or Rapid Diagnostics market are listed below:

- Roche

- Abbott

- Danaher

- Siemens Healthcare

- Bio-Rad Laboratories

- BioMerieux

- Nova Biomedical

- Thermo Fisher Scientific

- Quidel

- A. Menarini Diagnostics

- Becton Dickinson

- Biosurfit

- Astrego Diagnostics

- Werfen

- Abionic

- Palex Medical/Bülhmann

- Horiba Medical

- RAL

- Vircell

- Monlab

- Binding Site

Market segment by Region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Point-Of-Care Or Rapid Diagnostics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Point-Of-Care Or Rapid Diagnostics, with price, sales, revenue and global market share of Point-Of-Care Or Rapid Diagnostics from 2019 to 2021.

Chapter 3, the Point-Of-Care Or Rapid Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Point-Of-Care Or Rapid Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Point-Of-Care Or Rapid Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Point-Of-Care Or Rapid Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Point-of-Care or Rapid Diagnostics Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Point-Of-Care Or Rapid Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Point-Of-Care Or Rapid Diagnostics Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Intensive Care
1.2.3 Covid-19 Testing
1.2.4 Infectious Diseases Testing
1.2.5 Cardiac Markers Testing
1.2.6 Coagulation Testing
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Point-Of-Care Or Rapid Diagnostics Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Independent Laboratories
1.3.5 Others
1.4 Global Point-Of-Care Or Rapid Diagnostics Market Size & Forecast
1.4.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Value (2016-2026))
1.4.2 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume (2016-2026)
1.4.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2016-2026) & (US$/Dose)
1.5 Global Point-Of-Care Or Rapid Diagnostics Production Capacity Analysis
1.5.1 Global Point-Of-Care Or Rapid Diagnostics Total Production Capacity (2016-2026)
1.5.2 Global Point-Of-Care Or Rapid Diagnostics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Point-Of-Care Or Rapid Diagnostics Market Drivers
1.6.2 Point-Of-Care Or Rapid Diagnostics Market Restraints
1.6.3 Point-Of-Care Or Rapid Diagnostics Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Point-Of-Care Or Rapid Diagnostics Product and Services
2.1.4 Roche Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Product and Services
2.2.4 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Danaher
2.3.1 Danaher Details
2.3.2 Danaher Major Business
2.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Product and Services
2.3.4 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Siemens Healthcare
2.4.1 Siemens Healthcare Details
2.4.2 Siemens Healthcare Major Business
2.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product and Services
2.4.4 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Bio-Rad Laboratories
2.5.1 Bio-Rad Laboratories Details
2.5.2 Bio-Rad Laboratories Major Business
2.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product and Services
2.5.4 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 BioMerieux
2.6.1 BioMerieux Details
2.6.2 BioMerieux Major Business
2.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Product and Services
2.6.4 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Nova Biomedical
2.7.1 Nova Biomedical Details
2.7.2 Nova Biomedical Major Business
2.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product and Services
2.7.4 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product and Services
2.8.4 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Quidel
2.9.1 Quidel Details
2.9.2 Quidel Major Business
2.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Product and Services
2.9.4 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 A. Menarini Diagnostics
2.10.1 A. Menarini Diagnostics Details
2.10.2 A. Menarini Diagnostics Major Business
2.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product and Services
2.10.4 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Becton Dickinson
2.11.1 Becton Dickinson Details
2.11.2 Becton Dickinson Major Business
2.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product and Services
2.11.4 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Biosurfit
2.12.1 Biosurfit Details
2.12.2 Biosurfit Major Business
2.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Product and Services
2.12.4 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Astrego Diagnostics
2.13.1 Astrego Diagnostics Details
2.13.2 Astrego Diagnostics Major Business
2.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product and Services
2.13.4 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Werfen
2.14.1 Werfen Details
2.14.2 Werfen Major Business
2.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Product and Services
2.14.4 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Abionic
2.15.1 Abionic Details
2.15.2 Abionic Major Business
2.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Product and Services
2.15.4 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Palex Medical/Bülhmann
2.16.1 Palex Medical/Bülhmann Details
2.16.2 Palex Medical/Bülhmann Major Business
2.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product and Services
2.16.4 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Horiba Medical
2.17.1 Horiba Medical Details
2.17.2 Horiba Medical Major Business
2.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product and Services
2.17.4 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 RAL
2.18.1 RAL Details
2.18.2 RAL Major Business
2.18.3 RAL Point-Of-Care Or Rapid Diagnostics Product and Services
2.18.4 RAL Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Vircell
2.19.1 Vircell Details
2.19.2 Vircell Major Business
2.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Product and Services
2.19.4 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Monlab
2.20.1 Monlab Details
2.20.2 Monlab Major Business
2.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Product and Services
2.20.4 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Binding Site
2.21.1 Binding Site Details
2.21.2 Binding Site Major Business
2.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Product and Services
2.21.4 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Point-Of-Care Or Rapid Diagnostics Sales by Manufacturer
3.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Point-Of-Care Or Rapid Diagnostics
3.4 Market Concentration Rate
3.4.1 Top 3 Point-Of-Care Or Rapid Diagnostics Manufacturer Market Share
3.4.2 Top 6 Point-Of-Care Or Rapid Diagnostics Manufacturer Market Share
3.5 Global Point-Of-Care Or Rapid Diagnostics Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Point-Of-Care Or Rapid Diagnostics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Point-Of-Care Or Rapid Diagnostics Market Size by Region
4.1.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume by Region (2016-2026)
4.1.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2026)
4.2 North America Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026)
4.3 Europe Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026)
4.4 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026)
4.5 South America Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026)
4.6 Middle East and Africa Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume by Type (2016-2026)
5.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2016-2026)
5.3 Global Point-Of-Care Or Rapid Diagnostics Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Point-Of-Care Or Rapid Diagnostics Sales in Volume by Application (2016-2026)
6.2 Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2016-2026)
6.3 Global Point-Of-Care Or Rapid Diagnostics Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2026)
7.2 North America Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2026)
7.3 North America Point-Of-Care Or Rapid Diagnostics Market Size by Country
7.3.1 North America Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2016-2026)
7.3.2 North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2026)
8.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2026)
8.3 Europe Point-Of-Care Or Rapid Diagnostics Market Size by Country
8.3.1 Europe Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2016-2026)
8.3.2 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2026)
9.2 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2026)
9.3 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Market Size by Region
9.3.1 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2026)
10.2 South America Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2026)
10.3 South America Point-Of-Care Or Rapid Diagnostics Market Size by Country
10.3.1 South America Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2016-2026)
10.3.2 South America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2026)
11.2 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2026)
11.3 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Market Size by Country
11.3.1 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Point-Of-Care Or Rapid Diagnostics Typical Distributors
12.3 Point-Of-Care Or Rapid Diagnostics Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type, (USD Million), 2021-2026
Table 2. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Point-Of-Care Or Rapid Diagnostics Product and Services
Table 6. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Major Business
Table 9. Abbott Point-Of-Care Or Rapid Diagnostics Product and Services
Table 10. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Danaher Basic Information, Manufacturing Base and Competitors
Table 12. Danaher Major Business
Table 13. Danaher Point-Of-Care Or Rapid Diagnostics Product and Services
Table 14. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 16. Siemens Healthcare Major Business
Table 17. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product and Services
Table 18. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Bio-Rad Laboratories Major Business
Table 21. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product and Services
Table 22. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 24. BioMerieux Major Business
Table 25. BioMerieux Point-Of-Care Or Rapid Diagnostics Product and Services
Table 26. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Nova Biomedical Basic Information, Manufacturing Base and Competitors
Table 28. Nova Biomedical Major Business
Table 29. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product and Services
Table 30. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 32. Thermo Fisher Scientific Major Business
Table 33. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product and Services
Table 34. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Quidel Basic Information, Manufacturing Base and Competitors
Table 36. Quidel Major Business
Table 37. Quidel Point-Of-Care Or Rapid Diagnostics Product and Services
Table 38. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. A. Menarini Diagnostics Basic Information, Manufacturing Base and Competitors
Table 40. A. Menarini Diagnostics Major Business
Table 41. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product and Services
Table 42. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table 44. Becton Dickinson Major Business
Table 45. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product and Services
Table 46. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Biosurfit Basic Information, Manufacturing Base and Competitors
Table 48. Biosurfit Major Business
Table 49. Biosurfit Point-Of-Care Or Rapid Diagnostics Product and Services
Table 50. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Astrego Diagnostics Basic Information, Manufacturing Base and Competitors
Table 52. Astrego Diagnostics Major Business
Table 53. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product and Services
Table 54. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Werfen Basic Information, Manufacturing Base and Competitors
Table 56. Werfen Major Business
Table 57. Werfen Point-Of-Care Or Rapid Diagnostics Product and Services
Table 58. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Abionic Basic Information, Manufacturing Base and Competitors
Table 60. Abionic Major Business
Table 61. Abionic Point-Of-Care Or Rapid Diagnostics Product and Services
Table 62. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Palex Medical/Bülhmann Basic Information, Manufacturing Base and Competitors
Table 64. Palex Medical/Bülhmann Major Business
Table 65. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product and Services
Table 66. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Horiba Medical Basic Information, Manufacturing Base and Competitors
Table 68. Horiba Medical Major Business
Table 69. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product and Services
Table 70. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. RAL Basic Information, Manufacturing Base and Competitors
Table 72. RAL Major Business
Table 73. RAL Point-Of-Care Or Rapid Diagnostics Product and Services
Table 74. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Vircell Basic Information, Manufacturing Base and Competitors
Table 76. Vircell Major Business
Table 77. Vircell Point-Of-Care Or Rapid Diagnostics Product and Services
Table 78. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Monlab Basic Information, Manufacturing Base and Competitors
Table 80. Monlab Major Business
Table 81. Monlab Point-Of-Care Or Rapid Diagnostics Product and Services
Table 82. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Binding Site Basic Information, Manufacturing Base and Competitors
Table 84. Binding Site Major Business
Table 85. Binding Site Point-Of-Care Or Rapid Diagnostics Product and Services
Table 86. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Global Point-Of-Care Or Rapid Diagnostics Sales by Manufacturer (2019-2021e) & (K Doses)
Table 88. Global Point-Of-Care Or Rapid Diagnostics Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 89. Market Position of Manufacturers in Point-Of-Care Or Rapid Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 90. Global Point-Of-Care Or Rapid Diagnostics Production Capacity by Company, (K Doses): 2020 VS 2021
Table 91. Head Office and Point-Of-Care Or Rapid Diagnostics Production Site of Key Manufacturer
Table 92. Point-Of-Care Or Rapid Diagnostics New Entrant and Capacity Expansion Plans
Table 93. Point-Of-Care Or Rapid Diagnostics Mergers & Acquisitions in the Past Five Years
Table 94. Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2016-2021e) & (K Doses)
Table 95. Global Point-Of-Care Or Rapid Diagnostics Sales by Region (2021-2026) & (K Doses)
Table 96. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2021e) & (USD Million)
Table 97. Global Point-Of-Care Or Rapid Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 98. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2021e) & (K Doses)
Table 99. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2021-2026) & (K Doses)
Table 100. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2016-2021e) & (USD Million)
Table 101. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 102. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2016-2021e) & (US$/Dose)
Table 103. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2021-2026) & (US$/Dose)
Table 104. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2021e) & (K Doses)
Table 105. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2021-2026) & (K Doses)
Table 106. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2016-2021e) & (USD Million)
Table 107. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 108. Global Point-Of-Care Or Rapid Diagnostics Price by Application (2016-2021e) & (US$/Dose)
Table 109. Global Point-Of-Care Or Rapid Diagnostics Price by Application (2021-2026) & (US$/Dose)
Table 110. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021e) & (K Doses)
Table 111. North America Point-Of-Care Or Rapid Diagnostics Sales by Country (2021-2026) & (K Doses)
Table 112. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021e) & (USD Million)
Table 113. North America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 114. North America Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2021e) & (K Doses)
Table 115. North America Point-Of-Care Or Rapid Diagnostics Sales by Type (2021-2026) & (K Doses)
Table 116. North America Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2021e) & (K Doses)
Table 117. North America Point-Of-Care Or Rapid Diagnostics Sales by Application (2021-2026) & (K Doses)
Table 118. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021e) & (K Doses)
Table 119. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2021-2026) & (K Doses)
Table 120. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021e) & (USD Million)
Table 121. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 122. Europe Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2021e) & (K Doses)
Table 123. Europe Point-Of-Care Or Rapid Diagnostics Sales by Type (2021-2026) & (K Doses)
Table 124. Europe Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2021e) & (K Doses)
Table 125. Europe Point-Of-Care Or Rapid Diagnostics Sales by Application (2021-2026) & (K Doses)
Table 126. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region (2016-2021e) & (K Doses)
Table 127. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Region (2021-2026) & (K Doses)
Table 128. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region (2016-2021e) & (USD Million)
Table 129. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 130. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2021e) & (K Doses)
Table 131. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Type (2021-2026) & (K Doses)
Table 132. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2021e) & (K Doses)
Table 133. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Sales by Application (2021-2026) & (K Doses)
Table 134. South America Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021e) & (K Doses)
Table 135. South America Point-Of-Care Or Rapid Diagnostics Sales by Country (2021-2026) & (K Doses)
Table 136. South America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021e) & (USD Million)
Table 137. South America Point-Of-Care Or Rapid Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 138. South America Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2021e) & (K Doses)
Table 139. South America Point-Of-Care Or Rapid Diagnostics Sales by Type (2021-2026) & (K Doses)
Table 140. South America Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2021e) & (K Doses)
Table 141. South America Point-Of-Care Or Rapid Diagnostics Sales by Application (2021-2026) & (K Doses)
Table 142. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2016-2021e) & (K Doses)
Table 143. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2021-2026) & (K Doses)
Table 144. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2016-2021e) & (USD Million)
Table 145. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 146. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type (2016-2021e) & (K Doses)
Table 147. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type (2021-2026) & (K Doses)
Table 148. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application (2016-2021e) & (K Doses)
Table 149. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application (2021-2026) & (K Doses)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Point-Of-Care Or Rapid Diagnostics Typical Distributors
Table 153. Point-Of-Care Or Rapid Diagnostics Typical Customers
List of Figures
Figure 1. Point-Of-Care Or Rapid Diagnostics Picture
Figure 2. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type in 2020
Figure 3. Intensive Care
Figure 4. Covid-19 Testing
Figure 5. Infectious Diseases Testing
Figure 6. Cardiac Markers Testing
Figure 7. Coagulation Testing
Figure 8. Others
Figure 9. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application in 2020
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Independent Laboratories
Figure 13. Others
Figure 14. Global Point-Of-Care Or Rapid Diagnostics Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 15. Global Point-Of-Care Or Rapid Diagnostics Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Point-Of-Care Or Rapid Diagnostics Sales (2016-2026) & (K Doses)
Figure 17. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2016-2026) & (US$/Dose)
Figure 18. Global Point-Of-Care Or Rapid Diagnostics Production Capacity (2016-2026) & (K Doses)
Figure 19. Global Point-Of-Care Or Rapid Diagnostics Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Point-Of-Care Or Rapid Diagnostics Market Drivers
Figure 21. Point-Of-Care Or Rapid Diagnostics Market Restraints
Figure 22. Point-Of-Care Or Rapid Diagnostics Market Trends
Figure 23. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Manufacturer in 2020
Figure 24. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Manufacturer in 2020
Figure 25. Point-Of-Care Or Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Point-Of-Care Or Rapid Diagnostics Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Point-Of-Care Or Rapid Diagnostics Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2016-2026)
Figure 29. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2016-2026)
Figure 30. North America Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026) & (USD Million)
Figure 31. Europe Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026) & (USD Million)
Figure 33. South America Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue (2016-2026) & (USD Million)
Figure 35. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2016-2026)
Figure 36. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2016-2026)
Figure 37. Global Point-Of-Care Or Rapid Diagnostics Price by Type (2016-2026) & (US$/Dose)
Figure 38. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2016-2026)
Figure 39. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2016-2026)
Figure 40. Global Point-Of-Care Or Rapid Diagnostics Price by Application (2016-2026) & (US$/Dose)
Figure 41. North America Point-Of-Care Or Rapid Diagnostics Sales Market
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs